Study of a High-Risk Group of Stage II Colon Cancer

被引:0
|
作者
Hirosawa, Tomoichiro [1 ]
Itabashi, Michio [1 ]
Bamba, Yoshiko [1 ]
Ogawa, Shinpei [1 ]
Sirotani, Noriyasu [1 ]
Kameoka, Shingo [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Surg 2, Sch Med, Sinjuku Ku, Tokyo 1628666, Japan
关键词
Colon cancer; Stage II; Adjuvant chemotherapy; RECTAL-CANCER; EFFICACY; FLUOROURACIL; TRIAL;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study was conducted for the purpose of identifying a high-risk group for recurrence of stage II colon cancer and determine those cases for which postoperative adjuvant chemotherapy for stage II colon cancer is indicated. The subjects of this study consisted of 179 stage II cases and 114 stage IIIa cases among 462 surgical colon cancer cases examined at this department from January 1, 1991 to December 31, 1996 classified as A for the degree of cure, with the exception of m cancer. A nonrecurrence group and a recurrence group of stage II and stage IIIa colon cancer cases were compared on the basis of parameters. Gender, age, and lymph ducts were extracted from multivariate analysis, while age and lymph ducts were extracted from a survival analysis using the Cox proportional hazard model. A high-risk group for recurrence of stage II colon cancer was determined to consist of young men of ly 2.3. Since the nonrecurrence survival rates and survival prognoses of ly 2.3 cases in particular were equivalent to those of stage IIIa, this is considered to be a risk factor for recurrence of stage II colon cancer, and postoperative chemotherapy is believed to be indicated.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 50 条
  • [1] IDENTIFICATION OF HIGH-RISK PATIENTS IN STAGE II COLON CANCER
    Lanza, Giovanni
    Gafa, Roberta
    Santini, Alessandra
    Maestri, Iva
    Guerzoni, Laura
    Liboni, Alberto
    Azzena, Gianfranco
    Lelli, Giorgio
    Cavazzini, Luigi
    ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
  • [2] Biomarker for high-risk patients with stage II colon cancer
    Watanabe, Toshiaki
    LANCET ONCOLOGY, 2013, 14 (13): : 1247 - 1248
  • [3] Identification of Risk Factors for Recurrence in High-Risk Stage II Colon Cancer
    Hatano, Satoshi
    Ishida, Hideyuki
    Ishibashi, Keiichiro
    Kumamoto, Kensuke
    Haga, Norihiro
    Miura, Ichiro
    INTERNATIONAL SURGERY, 2013, 98 (02) : 114 - 121
  • [4] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [5] High-Risk Stage II Colon Cancer After Curative Resection
    Sato, Harunobu
    Maeda, Koutarou
    Sugihara, Kenichi
    Mochizuki, Hidetaka
    Kotake, Kenjiro
    Teramoto, Tetsuo
    Kameoka, Shingo
    Saito, Yukio
    Takahashi, Keiichi
    Hirai, Takashi
    Ohue, Masayuki
    Shirouzu, Kazuo
    Sakai, Yoshiharu
    Watanabe, Toshiaki
    Hirata, Koichi
    Hatakeyama, Katsuyoshi
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (01) : 45 - 52
  • [6] Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study
    Butare, Annmarie
    Sutton, Tia
    Kantzler, Elizabeth
    Kennedy, Katie N.
    Tumin, Dmitry
    Honaker, Michael D.
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [7] Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study
    Artac, Mehmet
    Turha, Nazim Serdar
    Kocer, Murat
    Karabulut, Bulent
    Bozcuk, Hakan
    Yalcin, Suayip
    Karaagac, Mustafa
    Gunduz, Seyda
    Isik, Nalan
    Uygunl, Kazinn
    TUMORI JOURNAL, 2014, 100 (02): : 143 - 148
  • [8] High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer
    Morimoto, Yoshihiro
    Takahashi, Hidekazu
    Arita, Asami
    Itakura, Hiroaki
    Fujii, Makoto
    Sekido, Yuki
    Hata, Tsuyoshi
    Fujino, Shiki
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Uemura, Mamoru
    Matsuda, Chu
    Yamamoto, Hirofumi
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Eguchi, Hidetoshi
    ONCOLOGY LETTERS, 2022, 23 (05)
  • [9] High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal
    Babcock, Blake D.
    Aljehani, Mayada A.
    Jabo, Brice
    Choi, Audrey H.
    Morgan, John W.
    Selleck, Matthew J.
    Luca, Fabrizio
    Raskin, Elizabeth
    Reeves, Mark E.
    Garberoglio, Carlos A.
    Lum, Sharon S.
    Senthil, Maheswari
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (07) : 1980 - 1985
  • [10] High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal
    Blake D. Babcock
    Mayada A. Aljehani
    Brice Jabo
    Audrey H. Choi
    John W. Morgan
    Matthew J. Selleck
    Fabrizio Luca
    Elizabeth Raskin
    Mark E. Reeves
    Carlos A. Garberoglio
    Sharon S. Lum
    Maheswari Senthil
    Annals of Surgical Oncology, 2018, 25 : 1980 - 1985